Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Over 20 industry experts on Inhalaltion Drug Delivery to gather in Berlin on 11 - 12 September 2013

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
CPhI Conferences introduces its inaugural conference on Inhalation Drug Delivery, to cover topics from particle engineering to device manufacture.

The potential of a pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving an undeniable attention with the recent advances of the inhalation drug delivery showing significant promise.  The crucial formulation considerations for orally inhaled products together with those of a delivery device play a major role in the efficiency of pulmonary delivery, and great strides have been made in the development of new formulation techniques and devices in recent years.

With this in mind, CPhI Conferences, is proud to present its inaugural conference on Inhalation Drug Delivery which has been designed to examine all the important aspects of pulmonary drug delivery, from particle engineering to device manufacturing.

Over the course of two intensive days there will be practical and informative sessions examining technical, physiological, and efficacy aspects of the novel pulmonary route of drug targeting. It will share important insights into the mechanisms of pulmonary drug administration along with compatibility of the excipients employed, devices used, and techniques of particulate dosage production.

This is an essential opportunity to understand the challenges facing the development of pulmonary drug delivery system and discover the opportunities for the pharmaceutical scientists to minimize the clinical and technical gaps.

In addition to the main conference, CPhI is also running a Pre-Conference Workshop on Nasal Drug Delivery providing hands-on, practical guidance on how to capitalise on the full potential of delivering drugs via the nasal route.

The conference will include industry professionals from a range of organisations including MHRA, Catalent, Glenmark, Hovione, Medicon Valley Inhalation Consortium, KAER Biotherapeutics, Nonomol Technologies and many more. With expert speakers from the world of pulmonary drug delivery across Europe and globally, this conference offers the opportunity to network and debate with leaders in this field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!